Increases in vaccination rates for human papillomavirus (HPV) are trailing increases in rates for two other vaccines recommended for teens and preteens, according to data from the Centers for Disease Control and Prevention.
Coverage rates for the other two vaccines —Tdap, which protects against tetanus, diphtheria and pertussis, and MenACWY, which protects against meningococcal meningitis—are continuing to increase, but vaccination rates for HPV vaccine remain low, the study found.
HPV infection can lead to cervical cancer, but vaccination dramatically reduces this risk.
The study in CDC’s Morbidity and Mortality Weekly Report drew on data from the 2010 National Immunization Survey-Teen.
“More U.S. teens are being protected against these serious, and sometimes deadly, diseases,” said Anne Schuchat, M.D., director of the CDC’s National Center for Immunization and Respiratory Diseases. “However, the HPV results are very concerning. Our progress is stagnating, and if we don’t make major changes, far too many girls in this generation will remain vulnerable to cervical cancer later in life."
Cervical cancer
About 6 million people become infected with HPV each year, and the CDC reports that every year, about 12,000 women will be diagnosed with cervical cancer.
CDC recommends HPV vaccine for 11- or 12-year-old girls to protect against the types of HPV that cause cervical cancer and also recommends teenage girls who have not yet been vaccinated with HPV vaccine complete the vaccination series. HPV vaccines are given in three doses (as shots) over six months. To ensure the highest level of protection, girls must complete all three shots.
The CDC NIS-Teen survey found:
- Coverage for the three routine teen vaccines was 49 percent for one dose of HPV vaccine; 63 percent for MenACWY; and 69 percent for Tdap vaccine.
- For girls who received the recommended three doses of HPV vaccine, coverage increased 5.3 points to 32 percent over the previous year.
- Hispanics had higher coverage for one dose of MenACWY and HPV, but third-dose HPV coverage lagged for blacks and Hispanics compared with whites. Girls living in poverty were also less likely to complete the HPV series.
- Coverage increases for HPV were less than half of the increases seen for Tdap (13.3 points) and meningitis (9.1 points) vaccines.
Continued improvements in MenACWY and Tdap are important. With 27,550 cases of pertussis reported in 2010 – 4,858 in 11- to 18-year-olds – it is critical that preteens get their Tdap vaccine. “This one-time dose of Tdap can prevent pertussis infection,” said Dr. Schuchat. “Also, preteens and teens who get vaccinated with MenACWY are protecting themselves from an infection that can lead to lifelong disability – or, in some cases, death in 48 hours or less. Let’s make sure all teens are protected.”
Dr. Schuchat stressed that any visit to the doctor—such as annual health checkup or physicals for sports, camp, or college—can be a good time for preteens and teens to get the recommended vaccinations.
By making sure all recommended vaccines are given at every opportunity, coverage for all the teen vaccines could increase substantially.
Cori Welch (Sat, 27 Aug 2011 11:10:02 +0000): Starting this year your child (or children) cannot be denied coverage simply because they have a pre-existing health condition. If you don't have insurance for you and your children search "Penny Health" online they are the best.